Cannabidiol (CBD) Market Analysis Pr

1
Global Cannabidiol (CBD) Market Growth to be
Propelled by Growth of Target Diseases,
Prevalence of Anxiety and Depression and Growth
of Cosmetic Industry by CAGR of 21 During 2022
2031 Kenneth Research published a report
titled Cannabidiol (CBD) Market Global Demand
Analysis Opportunity Outlook 2031 which
delivers detailed overview of the global
cannabidiol (CBD) market in terms of market
segmentation by source, product, distribution
channel, application, route of administration,
and by region. Further, for the in-depth
analysis, the report encompasses the industry
growth indicators, restraints, supply and demand
risk, along with detailed discussion on current
and future market trends that are associated with
the growth of the market.
The global cannabidiol (CBD) market is expected
to hold a revenue of USD 48 billion by 2031
growing from USD 5 billion in 2021. The market
growth can be attributed to the growth of
diseases demanding treatment with CBD, conditions
like anxiety,
2
depression, and chronic pain, the rise of
skincare, legalization of medical use of
cannabis, and the growing health consciousness
among the general population. The global
cannabidiol (CBD) market is expected to grow at a
CAGR of approximately 21 from 2022-2031. The
market is segmented by source into marijuana and
hemp. Between these, the marijuana segment is
anticipated to hold the largest market share by
the end of 2031, owing to the wide legalization
of the use of medical marijuana, and the
effectiveness of the medicine in relieving the
symptoms of several diseases. Full Report
Description https//www.kennethresearch.com/repor
t- details/cannabidiol-cbd-market/10159235 The
global cannabidiol (CBD) market is divided into
five major regions, including North America,
Europe, Asia Pacific, Latin America, and Middle
East Africa. The market in North America is
projected to hold the largest market share by the
end of 2031, backed by a large share of
disposable income per capita, legalization of the
purchase and use of marijuana, and the
prevalence of anxiety disorder. The research is
global in nature and covers detailed analysis on
the market in North America (U.S., Canada),
Europe (U.K., Germany, France, Italy, Spain,
Hungary, Belgium, Netherlands Luxembourg,
NORDIC Finland, Sweden, Norway, Denmark,
Poland, Turkey, Russia, Rest of Europe), Latin
America (Brazil, Mexico, Argentina, Rest of
Latin America), Asia-Pacific (China, India,
Japan, South Korea, Indonesia, Singapore,
Malaysia, Australia, New Zealand, Rest of
Asia-Pacific), Middle East and Africa (Israel,
GCC Saudi Arabia, UAE, Bahrain, Kuwait, Qatar,
Oman, North Africa, South Africa, Rest of
Middle East and Africa). In addition, analysis
comprising market size, Y-O-Y growth
opportunity analysis, market players competitive
study, investment opportunities, demand for
future outlook etc. has also been covered and
displayed in the research report. Effective Use
in the Treatment of Anxiety and Depression to
Boost the Market Growth
3
CBD is effectively used to reduce the symptoms of
anxiety and depression worldwide. Hence the wide
prevalence of these mental health conditions is
thought to increase the demand for the
same. More than 250 million adults globally are
believed to suffer from anxiety disorder with
over 60 of this population being women. In the
same way, women are more than men in up to 6 of
the world population believed to suffer from
depression. Additionally, stress has been
observed to trigger the symptoms of anxiety and
depression in some people globally. However,
difficulties in manufacturing and sales of CBD
products during COVID-19, CBD products being
expensive, and the strict rules against the use
of CBD in some parts of the world are expected
to operate as key restraints to the growth of the
global cannabidiol (CBD) market over the
forecast period. This report also provides the
existing competitive scenario of some of the key
players of the global cannabidiol (CBD) market
which includes company profiling of Endoca,
Cannoid, LLC, Medical Marijuana, Inc., Folium
Biosciences, Elixinol, Aurora Cannabis Inc.,
Medterra CBD, CV Sciences, Inc., PharmaHemp,
NuLeaf Naturals, LLC, and others. The profiling
enfolds key information of the companies which
encompasses business overview, products and
services, key financials and recent news and
developments. On the whole, the report depicts
detailed overview of the global cannabidiol (CBD)
market that will help industry consultants,
equipment manufacturers, existing players
searching for expansion opportunities, new
players searching possibilities and other
stakeholders to align their market centric
strategies according to the ongoing and expected
trends in the future. Request Report Sample_at_
https//www.kennethresearch.com/sample-request-
10159235 Kenneth Research is a leading service
provider for strategic market research and
consulting. We aim to provide unbiased,
unparalleled market insights and industry
analysis to help industries, conglomerates and
executives to take wise decisions for their
4
future marketing strategy, expansion and
investment etc. We believe every business can
expand to its new horizon, provided a right
guidance at a right time is available through
strategic minds. Our out of box thinking helps
our clients to take wise decision in order to
avoid future uncertainties. Contact for more
Info AJ Daniel Email sales_at_kennethresearch.com
U.S. Phone [phone]